Full Breakdown
Colossal Biosciences Launches Bluebuck De-Extinction Project
5/2/2026, 11:11:45 AM
Bluebuck De-Extinction Initiative Launched
Dallas-based Colossal Biosciences announced that the extinct South African antelope *Hippotragus leucophaeus* (bluebuck) has joined its de-extinction portfolio. The company plans to edit the genome of the roan antelope, its closest living relative, create embryos, and implant them in surrogate roan mothers, with a gestation period of roughly nine months.
Historical Context of the Bluebuck
The bluebuck inhabited the coastal grasslands of South Africa’s southwestern Cape until European colonists hunted it to extinction by 1800, just 34 years after its first scientific description. Its distinctive silvery-blue coat and backward-curving horns made it a prized target for the fur trade.
Key Players and Partnerships
- Ben Lamm – CEO and co-founder of Colossal Biosciences.
- Beth Shapiro – Chief Science Officer, overseeing genomic work.
- Matt James – Chief Animal Officer, leading reproductive-technology efforts.
- Scott Barish – Genome engineer involved in variant filtering.
- Endangered Wildlife Trust – Partner identifying potential re-wilding sites in South Africa.
- Swedish Museum of Natural History – Source of the mounted bluebuck skin used for DNA extraction.
Scientific Progress and Technical Milestones
Colossal has assembled a 40-fold coverage bluebuck genome and confirmed >98 % genomic similarity with the roan antelope. Induced pluripotent stem cells (iPSCs) have been derived from roan cells, and ovum-pickup (OPU) techniques successfully harvested oocytes from roan antelopes and scimitar-horned oryx. The project is now in the genome-editing phase, inserting identified bluebuck-specific edits into roan iPSCs before embryo creation.
Conservation Significance
Globally, ~90 antelope species exist; 29 are classified as threatened, representing roughly one-third of the group. Colossal argues that tools developed for the bluebuck—high-coverage genome assembly, scalable OPU, and genome editing—can be applied to other at-risk bovids, addressing a historically underfunded conservation sector.
Official Statements & Responses
Colossal officials emphasized a moral imperative to rectify historic human-caused extinction, highlighted the technical readiness of genome-editing pipelines, and framed the debate on de-extinction as a distraction from broader conservation failures. Shapiro stressed that antelopes have lagged behind megafauna in receiving advanced reproductive technologies. James described the OPU protocols as “game-changers” for breeding programs. The company also noted ongoing collaborations with South African conservation groups to secure suitable habitats for future releases.
Criticism & Opposition
Ethicists and some wildlife scientists question the ecological value of resurrecting extinct species and caution that de-extinction may divert resources from protecting extant populations. Independent experts have labeled the previously announced “de-extincted” dire wolves as genetically modified gray wolves, underscoring concerns about terminology and scientific rigor.
Conflicting Reports & Gaps
Sources differ on the classification of the dire wolf project: Colossal markets it as the first successful de-extinction, while external experts describe the animals as edited gray wolves. No independent verification of successful bluebuck embryo implantation or gestation has been reported, leaving a gap in outcome data.
Verbatim Quotes
- “Humans did this. European settlers shot the bluebuck out of the Cape in under 34 years. There's no ambiguity about the cause and there's no ambiguity about the responsibility. If we have the capability to right that wrong, I think we have an obligation to,” — Ben Lamm, CEO, Colossal Biosciences
- “Honestly, I think the debate sometimes functions as a way to avoid a harder conversation, which is that conservation as currently practiced is not winning. We are losing species faster than our existing toolkit can address,” — Ben Lamm, CEO, Colossal Biosciences
- “The specialized ovum pickup protocols we’ve developed for antelopes are game-changers for conservation breeding,” — Matt James, Chief Animal Officer, Colossal Biosciences
- “Then we got it down to 2.4 million truly functional regions of the genome and then narrowed our focus to what are truly key phenotypes and got down to about 20,000. It's so much more manageable but still an imposing number.” — Scott Barish, Genome Engineer, Colossal Biosciences
What’s Next
Colossal will complete genome edits, generate embryos, and implant them in surrogate roan mothers within the next two years. Parallel efforts will scale OPU techniques to additional endangered bovids and finalize habitat assessments with the Endangered Wildlife Trust for eventual re-wilding of a pilot bluebuck population (10-20 individuals) before aiming for a self-sustaining wild herd. Further de-extinction updates on the mammoth, dodo, thylacine and moa are slated for release later this year.
